Physician profile
Jon M Rapacz
NPI 1225614852
$703.12
in general payments reported to CMS, 2019-2025
10 companies · $259 in 2025
The $259 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $203 · 2023: $14.61 · 2024: $227 · 2025: $259.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $500.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $169.20 | 2024 | Freestyle Libre 3 |
| Gilead Sciences, INC. | $124.91 | 2025 | Yeztugo |
| Biohaven Pharmaceuticals, INC. | $118.14 | 2021 | |
| Mannkind Corporation | $84.82 | 2021 | |
| Abbvie INC. | $66.46 | 2023-2025 | |
| Exact Sciences Corporation | $62.51 | 2024-2025 | Cologuard Collection Kit |
| Viiv Healthcare Company | $24.66 | 2025 | Cabenuva |
| Axsome Therapeutics, INC. | $18.76 | 2025 | Auvelity |
| Lilly USA, LLC | $18.00 | 2025 | Zepbound |
| Sanofi-Aventis U.S. LLC | $15.66 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jon Rapacz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.